Hematologic Disorders
SJ Grant, DC Jiang - Geriatric Medicine: A Person Centered Evidence …, 2023 - Springer
Hematologic disorders are a diverse group of malignant and nonmalignant conditions
arising from the blood and other hematopoietic sources. Many of the malignant disorders …
arising from the blood and other hematopoietic sources. Many of the malignant disorders …
Chronic myeloproliferative neoplasms in the elderly
M Maffioli, E Orlandi, F Passamonti - European journal of internal medicine, 2018 - Elsevier
This review focuses on the management of elderly patients with chronic myeloid leukemia
and chronic myeloproliferative neoplasms, including polycythemia vera, essential …
and chronic myeloproliferative neoplasms, including polycythemia vera, essential …
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid …
HL Yoo, SH Kim, SY Choi, SE Lee, DW Kim - Clinical Lymphoma Myeloma …, 2019 - Elsevier
Background In this study we aimed to evaluate appropriate time points for mutation analysis
of chronic myeloid leukemia. Patients and Methods In total, 961 blood samples obtained …
of chronic myeloid leukemia. Patients and Methods In total, 961 blood samples obtained …
γδ T cells number, CD200, and Flt3 expression is associated with higher progression free survival in patients with chronic myeloid leukemia
R Molina-Aguilar, LA Montiel-Cervantes… - Archives of Medical …, 2020 - Elsevier
Background Tumor immunoedition involves alterations in cells of immune system, which
may play an important role in the immunosurveillance of patients with cancer diseases. Aim …
may play an important role in the immunosurveillance of patients with cancer diseases. Aim …
[HTML][HTML] The challenges of precision medicine and new advances in molecular diagnostic testing in hematolymphoid malignancies: impact on the VHA
J Wang-Rodriguez, A Yunes, R Phan, N Ma… - Federal …, 2017 - ncbi.nlm.nih.gov
Abstract The Hematopathology Molecular Genetics subcommittee presents
recommendations for molecular diagnostic testing in acute myeloid leukemia …
recommendations for molecular diagnostic testing in acute myeloid leukemia …
[PDF][PDF] MINISTÉRIO DA SAÚDE SECRETARIA DE ATENÇÃO ESPECIALIZADA À SAÚDE SECRETARIA DE CIÊNCIA, TECNOLOGIA E INSUMOS ESTRATÉGICOS …
LOF DUARTE, HA NETO - gov.br
A insuficiência cardíaca (IC) é a via final de muitas doenças que afetam o coração, o que
explica a sua crescente prevalência. A atenção aos pacientes com IC é um desafio pelo …
explica a sua crescente prevalência. A atenção aos pacientes com IC é um desafio pelo …
[HTML][HTML] Изменение концентрации биомаркеров дисфункции эндотелия при приеме ингибиторов тирозинкиназы I и II поколений у пациентов с хроническим …
КВ Наумова, ИЛ Давыдкин, ЕГ Ломая… - Российский …, 2021 - russjcardiol.elpub.ru
Изменение концентрации биомаркеров дисфункции эндотелия при приеме
ингибиторов тирозинкиназы I и II поколений у пациентов с хроническим …
ингибиторов тирозинкиназы I и II поколений у пациентов с хроническим …
[HTML][HTML] Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a …
KV Naumova, IL Davydkin, EG Lomaia… - Российский …, 2020 - cyberleninka.ru
Aim. Identification of interrelation of endothelial dysfunction at patients with chronic myeloid
leukemia (CML), the accepting inhibitors tyrosine of kinases (TKI) I and the II generations …
leukemia (CML), the accepting inhibitors tyrosine of kinases (TKI) I and the II generations …
[PDF][PDF] gd T Cells Number, CD200, and Flt3 Expression Is Associated with Higher Progression Free Survival in Patients with Chronic Myeloid Leukemia
R Molina-Aguilar, LA Montiel-Cervantes - researchgate.net
Background. Tumor immunoedition involves alterations in cells of immune system, which
may play an important role in the immunosurveillance of patients with cancer diseases. Aim …
may play an important role in the immunosurveillance of patients with cancer diseases. Aim …
[PDF][PDF] LA PCR DIGITALE EN GOUTTELETTES, UNE NOUVELLE APPROCHE DU SUIVI DE LA MALADIE RESIDUELLE DANS LA LEUCEMIE MYELOÏDE …
N Mourad, K Ibtissem, A Amine… - Journal Algérien de …, 2021 - asjp.cerist.dz
Dans la leucémie myéloïde chronique (LMC) la rémission sans traitement (RST, en Anglais
treatment-free survival «TFR») par l'arrêt des inhibiteurs de la tyrosine kinase (ITK) chez les …
treatment-free survival «TFR») par l'arrêt des inhibiteurs de la tyrosine kinase (ITK) chez les …